Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Miami Gardens, FL
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Miami Gardens, FL
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Orlando, FL
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Pensacola, FL
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Pensacola, FL
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Sarasota, FL
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Tampa, FL
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Wilton Manors, FL
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Wilton Manors, FL
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Atlanta, GA
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Savannah, GA
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Chicago, IL
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Chicago, IL
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Worcester, MA
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Berkley, MI
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Berkley, MI
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Midland, MI
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Midland, MI
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
St. Louis, MO
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
St. Louis, MO
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Camden, NJ
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Camden, NJ
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Newark, NJ
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Mount Vernon, NY
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Mount Vernon, NY
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Charlotte, NC
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Raleigh, NC
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Cincinnati, OH
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Perrysburg, OH
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Perrysburg, OH
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Austin, TX
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Houston, TX
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Nassau Bay, TX
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Nassau Bay, TX
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Dallas, TX
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Dallas, TX
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Houston, TX
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Houston, TX
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Lynchburg, VA
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Seattle, WA
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated:  9/27/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Status: Enrolling
Updated: 9/27/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX
CID 1007 - Randomized Controlled Trial of an Augmented Test, Treat, Link & Retain Model for NC and TX Prisoners (imPACT Study)
Status: Enrolling
Updated:  10/9/2013
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX
CID 1007 - Randomized Controlled Trial of an Augmented Test, Treat, Link & Retain Model for NC and TX Prisoners (imPACT Study)
Status: Enrolling
Updated: 10/9/2013
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX
CID 1007 - Randomized Controlled Trial of an Augmented Test, Treat, Link & Retain Model for NC and TX Prisoners (imPACT Study)
Status: Enrolling
Updated:  10/9/2013
Texas Christian University
mi
from
Fort Worth, TX
Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX
CID 1007 - Randomized Controlled Trial of an Augmented Test, Treat, Link & Retain Model for NC and TX Prisoners (imPACT Study)
Status: Enrolling
Updated: 10/9/2013
Texas Christian University
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Body Image in Youth With HIV
Body Image in Youth With HIV
Status: Enrolling
Updated:  10/10/2013
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Body Image in Youth With HIV
Body Image in Youth With HIV
Status: Enrolling
Updated: 10/10/2013
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects
A Phase I, Open Label, Randomized, Three Period, Fixed Sequence Crossover Study to Evaluate the Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (200901)
Status: Enrolling
Updated:  10/17/2013
GSK Investigational Site
mi
from
Overland Park, KA
Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects
A Phase I, Open Label, Randomized, Three Period, Fixed Sequence Crossover Study to Evaluate the Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (200901)
Status: Enrolling
Updated: 10/17/2013
GSK Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated:  11/15/2013
IMMUNOe Health Centers
mi
from
Cenntennial, CO
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated: 11/15/2013
IMMUNOe Health Centers
mi
from
Cenntennial, CO
Click here to add this to my saved trials
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated:  11/15/2013
Allergy Associates of the Palm Beaches, PA
mi
from
North Palm Beach, FL
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated: 11/15/2013
Allergy Associates of the Palm Beaches, PA
mi
from
North Palm Beach, FL
Click here to add this to my saved trials
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated:  11/15/2013
Family Allergy Center, PC
mi
from
Atlanta, GA
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated: 11/15/2013
Family Allergy Center, PC
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated:  11/15/2013
South Bend Clinic, LLP
mi
from
South Bend, IN
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated: 11/15/2013
South Bend Clinic, LLP
mi
from
South Bend, IN
Click here to add this to my saved trials
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated:  11/15/2013
Asthma & Immunology Associates
mi
from
Omaha, NE
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated: 11/15/2013
Asthma & Immunology Associates
mi
from
Omaha, NE
Click here to add this to my saved trials
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated:  11/15/2013
Mount Sinai School of Medicine
mi
from
New York, NY
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated: 11/15/2013
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated:  11/15/2013
Dallas Immunology Research
mi
from
Dallas, TX
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated: 11/15/2013
Dallas Immunology Research
mi
from
Dallas, TX
Click here to add this to my saved trials
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated:  11/15/2013
AARA Research Center
mi
from
Dallas, TX
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated: 11/15/2013
AARA Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated:  11/15/2013
Baylor Texas Children's Hospital
mi
from
Houston, TX
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
An Open Label, Multicenter, Study to Evaluate the Pharmacokinetics, Efficacy and Safety of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated: 11/15/2013
Baylor Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Effectiveness of an Online Prevention Program in Reducing the Risk of STD Infection in Young Adults
Internet-based Efficacy Trial of an HIV Prevention Program
Status: Enrolling
Updated:  11/26/2013
Internet-Based, accessible from anywhere
mi
from
Bethesda, MD
Effectiveness of an Online Prevention Program in Reducing the Risk of STD Infection in Young Adults
Internet-based Efficacy Trial of an HIV Prevention Program
Status: Enrolling
Updated: 11/26/2013
Internet-Based, accessible from anywhere
mi
from
Bethesda, MD
Click here to add this to my saved trials
EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients
Efavirenz Pharmacokinetics and Pharmacogenomics in Older HIV-infected Patients
Status: Enrolling
Updated:  12/24/2013
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients
Efavirenz Pharmacokinetics and Pharmacogenomics in Older HIV-infected Patients
Status: Enrolling
Updated: 12/24/2013
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Gonorrhea and Chlamydia HIV-infected Men Who Have Sex With Men
Prevalence of Gonorrhea and Chlamydia Infections in Multiple Anatomical Sites in HIV-infected Men Who Have Sex With Men at an HIV Clinic in Omaha, Nebraska
Status: Enrolling
Updated:  12/24/2013
Specialty Care Center
mi
from
Omaha, NE
Gonorrhea and Chlamydia HIV-infected Men Who Have Sex With Men
Prevalence of Gonorrhea and Chlamydia Infections in Multiple Anatomical Sites in HIV-infected Men Who Have Sex With Men at an HIV Clinic in Omaha, Nebraska
Status: Enrolling
Updated: 12/24/2013
Specialty Care Center
mi
from
Omaha, NE
Click here to add this to my saved trials
UCLA-Amity Parolee Health Promotion Study
Health Promotion Coaching/Vaccine for Homeless Parolees
Status: Enrolling
Updated:  1/8/2014
Amistad de Los Angeles
mi
from
Los Angeles, CA
UCLA-Amity Parolee Health Promotion Study
Health Promotion Coaching/Vaccine for Homeless Parolees
Status: Enrolling
Updated: 1/8/2014
Amistad de Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Isentress Re-examination Study (MK-0518-115)
Re-examination Study for General Drug Use to Assess the Safety and Efficacy of ISENTRESS in Usual Practice
Status: Enrolling
Updated:  1/15/2014
Clinical Research Facility
mi
from
Peoria, IL
Isentress Re-examination Study (MK-0518-115)
Re-examination Study for General Drug Use to Assess the Safety and Efficacy of ISENTRESS in Usual Practice
Status: Enrolling
Updated: 1/15/2014
Clinical Research Facility
mi
from
Peoria, IL
Click here to add this to my saved trials